Medicare Enrolled
Dr. Walter Delgaudio, MD
Urology Physician · Plains, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delgaudio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delgaudio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delgaudio
Dr. Walter Delgaudio is an urology physician in Plains, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Delgaudio performed 3,177 Medicare services across 2,309 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delgaudio received a total of $21,138 from 36 pharmaceutical and/or device companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delgaudio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in PA
$21,138 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,177
Medicare services
Top 20% in PA for urology physician
2,309
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~167 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
855 | $57 | $125 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
405 | $3 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
370 | $88 | $200 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
285 | $7 | $50 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
184 | $170 | $500 |
| Simple change of bladder tube | 181 | $66 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $105 | $275 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $135 | $635 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
78 | $96 | $325 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $42 | $110 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
66 | $36 | $100 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
55 | $41 | $170 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $77 | $200 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
50 | $97 | $355 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
49 | $24 | $85 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
36 | $55 | $205 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
33 | $428 | $1,430 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
33 | $19 | $65 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $17 | $50 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $72 | $395 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $126 | $250 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
17 | $127 | $430 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
16 | $206 | $730 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
16 | $61 | $325 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
14 | $24 | $80 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $217 | $595 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
13 | $275 | $900 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
13 | $31 | $110 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
12 | $309 | $765 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
11 | $107 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
13.6% medium
84.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,138
Total received (2018-2024)
Avg $3,020/year across 7 years
Top 8% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
314
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,384 (82.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,754 (17.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$712
2023
$1,190
2022
$209
2021
$357
2020
$590
2019
$2,699
2018
$15,381
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$193
ABBVIE INC.
$108
Astellas Pharma US Inc
$92
Bayer Healthcare Pharmaceuticals Inc.
$57
Axonics, Inc.
$39
COLOPLAST CORP
$35
Merck Sharp & Dohme LLC
$34
Myriad Genetic Laboratories, Inc.
$31
180 Medical, Inc.
$30
Novartis Pharmaceuticals Corporation
$27
Endo Pharmaceuticals Inc.
$17
UROGEN PHARMA, INC.
$17
Janssen Biotech, Inc.
$17
PFIZER INC.
$14
Top 3 companies account for 55.2% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$16,855
Astellas Pharma US Inc
$996
PFIZER INC.
$427
AbbVie Inc.
$345
Myriad Genetic Laboratories, Inc.
$299
Medtronic, Inc.
$291
Sumitomo Pharma America, Inc.
$225
ABBVIE INC.
$148
MEDIVATION FIELD SOLUTIONS LLC
$131
TOLMAR Pharmaceuticals, Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$108
Axonics, Inc.
$101
Ferring Pharmaceuticals Inc.
$100
Allergan, Inc.
$98
Boston Scientific Corporation
$96
Janssen Biotech, Inc.
$88
Avadel Specialty Pharmaceuticals, LLC
$81
180 Medical, Inc.
$69
UroGen Pharma, Inc.
$66
AbbVie, Inc.
$52
Axonics Modulation Technologies, Inc.
$50
Novartis Pharmaceuticals Corporation
$43
Laborie Medical Technologies Corp.
$42
COLOPLAST CORP
$35
Merck Sharp & Dohme LLC
$34
Teleflex LLC
$33
Amgen Inc.
$33
Palette Life Sciences, Inc.
$33
Endo Pharmaceuticals Inc.
$28
Myovant Sciences Inc.
$24
Kowa Pharmaceuticals America, Inc.
$23
Cook Medical LLC
$17
UROGEN PHARMA, INC.
$17
Progenics Pharmaceuticals, Inc.
$14
PROCEPT BioRobotics Corporation
$12
Allergan Inc.
$11
Top 3 companies account for 86.5% of all-time payments
Associated products mentioned in payments ›
AKEEGA · AVEED · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · COOK · ELIGARD · ERLEADA · FIRMAGON · GEMTESA · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PYLARIFY · Prolaris · Prolia · Rezum Generator · SEGLENTIS · SPECTRA WAVEWRITER · SPEEDICATH · SpaceOAR VUE System - 10mL · SpeediCath · TOVIAZ · UROLIFT · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in PA.
Geographic Context
Urology physicians within 10 mi
20
Per 100K population
6.1
County median income
$62,321
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
10.3 mi
10.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Delgaudio is a clinical cardiology specialist, with above-average Medicare volume (top 20% in PA), with speaking/promotional industry engagement in the top 8% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Delgaudio experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Delgaudio performed 855 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delgaudio receive payments from pharmaceutical companies?
Yes. Dr. Delgaudio received a total of $21,138 from 36 companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delgaudio's costs compare to other urology physicians in Plains?
Dr. Delgaudio's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delgaudio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plains
Browse urology physicians in Plains ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology